Sites | Groups | Median (Range)(c) | P Value(d) (PCR Versus Non PCR) |
---|---|---|---|
Primary breast tumours, n = 33 (CD8+: FOXP3+ T cell ratio) | Tumours with pCR | 7.40 (0.27-45.00) | 0.002e |
Tumours with non pCR | 1.48 (0.18-6.04) | ||
ALN metastatic tumours, n = 20 (CD8+: FOXP3+ T cell ratio) | Metastatic tumours with pCR | 5.87 (1.35-21.92) | 0.080 |
Metastatic tumours with non pCR | 1.93 (0.40-7.20) | ||
ALNs, n = 24 (%CD8+: %FOXP3+ T cell ratio) | ALNs with pCR | 7.24 (3.33-75.00) | 0.006e |
ALNs with non pCR | 3.19 (1.78-8.00) |